Search Results

One-Year Data Presented From BIOSOLVE-IV Registry for Biotronik's Resorbable Magmaris Scaffold

March 5, 2019—Biotronik announced that preliminary results of the BIOSOLVE-IV study were presented by Clinical Investigator Stefano Galli, MD, as late-breaking clinical data at CRT 2019, the Cardiovascular Research Technologies annual meeting held March 2–5 in Washington, DC.

Elixir Medical’s LithiX Hertz Contact IVL System Approved and Launched in Europe

April 10, 2025—Elixir Medical announced European Union Medical Device Regulation—EU MDR—CE Mark approval of its LithiX Hertz Contact (HC) intravascular lithotripsy system (IVL) and the launch of the device in Europe.

Updated 1-Year BIOSOLVE-IV Data Presented for Biotronik's Magmaris Resorbable Scaffold

June 7, 2019–Biotronik announced that updated 12-month follow-up cohort results from the first 800 patients in the BIOSOLVE-IV registry were presented by the study's Principal Investigator Stefan Verheye, MD, at EuroPCR held May 21–24 in Paris, France.